Mitochondrial dysfunction in cholestatic liver diseases

Frontiers in Bioscience - Elite

Volumn 4 E, Issue 6, 2012, Pages 2233-2252

  Arduini, Alessandro ^a   Serviddio, Gaetano ^b   Tormos, Ana M ^a   Monsalve, Maria ^c   Sastre, Juan ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSITY OF FOGGIA   (Italy)

^c CSIC   (Spain)

Author keywords

Apoptosis; Bile acids; Mitochondrial function; Oxidative stress; Review

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ADENOSINE DIPHOSPHATE; CASPASE 8; CHAPERONIN 60; CYCLIC AMP DEPENDENT PROTEIN KINASE; DEATH RECEPTOR; GLUTATHIONE DISULFIDE; GLYCOCHENODEOXYCHOLIC ACID; MITOCHONDRIAL DNA; MITOCHONDRIAL PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; THIOREDOXIN REDUCTASE 1; TRANSCRIPTION FACTOR NRF1; TRANSCRIPTION FACTOR NRF2; UNCOUPLING PROTEIN 2; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; BILE DUCT LIGATION; BILIARY CIRRHOSIS; BIOGENESIS; CELL MEMBRANE FLUIDITY; CHOLESTASIS; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY YIELD; FATTY ACID OXIDATION; HUMAN; INTRAHEPATIC CHOLESTASIS; LIPID PEROXIDATION; LIVER CELL; LIVER INJURY; MITOCHONDRIAL DNA DEPLETION; MITOCHONDRIAL GENOME; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; LIVER DISEASE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

APOPTOSIS; CHOLESTASIS; HUMANS; LIVER DISEASES; MITOCHONDRIA; OXIDATIVE STRESS;

EID: 84860863773     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: None     Document Type: Article

References (172)

1. M. Trauner, P. J. Meier and J. L. Boyer: Molecular pathogenesis of cholestasis, N Engl J Med 339, 1217-1227 (1998))
2. E. A. Shaffer, Cholestasis: the ABCs of cellular mechanisms for impaired bile secretion - transporters and genes, Can J Gastroenterol 16, 380-389 (2002))
3. R. O. Elferink, Cholestasis, Gut 52 Suppl 2, ii42-8 (2003))
4. M. Wagner, G. Zollner and M. Trauner: New molecular insights into the mechanisms of cholestasis, J Hepatol 51, 565-580 (2009))
5. G. Alpini, S. S. Glaser, Y. Ueno, R. Rodgers, J. L. Phinizy, H. Francis, L. Baiocchi, L. A. Holcomb, A. Caligiuri and G. D. LeSage: Bile acid feeding induces cholangiocyte proliferation and secretion: evidence for bile acid-regulated ductal secretion, Gastroenterology 116, 179-186 (1999)) (Pubitemid 29013507)
6. M. K. Li and J. M. Crawford: The pathology of cholestasis, Semin Liver Dis 24, 21-42 (2004)) (Pubitemid 38496046)
7. E. J. Heathcote, Diagnosis and management of cholestatic liver disease, Clin Gastroenterol Hepatol 5, 776-782 (2007)) (Pubitemid 47039232)
8. S. O. BYERS and M. FRIEDMAN: Plasma cholesterol in rats following ligation of the bile duct and intravenous injection of free cholesterol, Am J Med 8, 535-536 (1950))
9. J. M. Johnstone and E. G. Lee: A quantitative assessment of the structural changes the rat's liver following obstruction of the common bile duct, Br J Exp Pathol 57, 85-94 (1976))
10. Y. Osawa, E. Seki, M. Adachi, K. Taura, Y. Kodama, S. V. Siegmund, R. F. Schwabe and D. A. Brenner: Systemic mediators induce fibrogenic effects in normal liver after partial bile duct ligation, Liver Int 26, 1138-1147 (2006)) (Pubitemid 44541755)
11. S. Heinrich, P. Georgiev, A. Weber, A. Vergopoulos, R. Graf and P. A. Clavien: Partial bile duct ligation in mice: a novel model of acute cholestasis, Surgery 149, 445-451 (2011))
12. P. Georgiev, W. Jochum, S. Heinrich, J. H. Jang, A. Nocito, F. Dahm and P. A. Clavien: Characterization of time-related changes after experimental bile duct ligation, Br J Surg 95, 646-656 (2008))
13. J. M. de Vree, E. Jacquemin, E. Sturm, D. Cresteil, P. J. Bosma, J. Aten, J. F. Deleuze, M. Desrochers, M. Burdelski, O. Bernard, R. P. Oude Elferink and M. Hadchouel: Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis, Proc Natl Acad Sci U S A 95, 282-287 (1998)) (Pubitemid 28103945)
14. I. Grattagliano, S. Russmann, C. V. Diogo, L. Bonfrate, P. J. Oliveira, D. Q. Wang and P. Portincasa: Mitochondria in Chronic Liver Disease, Curr Drug Targets (2011))
15. S. Krahenbuhl, Alterations in mitochondrial function and morphology in chronic liver disease: pathogenesis and potential for therapeutic intervention, Pharmacol Ther 60, 1-38 (1993)) (Pubitemid 24052880)
16. M. M. Tiao, T. K. Lin, C. W. Liou, P. W. Wang, J. B. Chen, F. Y. Kuo, C. C. Huang, Y. M. Chou and J. H. Chuang: Early transcriptional deregulation of hepatic mitochondrial biogenesis and its consequent effects on murine cholestatic liver injury, Apoptosis 14, 890-899 (2009))
17. A. Arduini, G. Serviddio, J. Escobar, A. M. Tormos, F. Bellanti, J. Vina, M. Monsalve and J. Sastre: Mitochondrial Biogenesis Fails in Secondary Biliary Cirrhosis in Rats Leading to Mitochondrial DNA Depletion and Deletions, Am J Physiol Gastrointest Liver Physiol 301, G119-27 (2011))
18. G. Serviddio, J. Pereda, F. V. Pallardo, J. Carretero, C. Borras, J. Cutrin, G. Vendemiale, G. Poli, J. Vina and J. Sastre: Ursodeoxycholic acid protects against secondary biliary cirrhosis in rats by preventing mitochondrial oxidative stress, Hepatology 39, 711-720 (2004)) (Pubitemid 38337650)
19. S. Krahenbuhl, C. Talos, S. Fischer and J. Reichen: Toxicity of bile acids on the electron transport chain of isolated rat liver mitochondria, Hepatology 19, 471-479 (1994)) (Pubitemid 24046794)
20. C. Lang, S. Berardi, M. Schafer, D. Serra, F. G. Hegardt, L. Krahenbuhl and S. Krahenbuhl: Impaired ketogenesis is a major mechanism for disturbed hepatic fatty acid metabolism in rats with long-term cholestasis and after relief of biliary obstruction, J Hepatol 37, 564-571 (2002)) (Pubitemid 35305534)
21. C. Lang, M. Schafer, D. Serra, F. Hegardt, L. Krahenbuhl and S. Krahenbuhl: Impaired hepatic fatty acid oxidation in rats with short-term cholestasis: characterization and mechanism, J Lipid Res 42, 22-30 (2001)) (Pubitemid 32142857)
22. L. Krahenbuhl, C. Talos, J. Reichen and S. Krahenbuhl: Progressive decrease in tissue glycogen content in rats with long-term cholestasis, Hepatology 24, 902-907 (1996)) (Pubitemid 26334292)
23. B. L. Copple, H. Jaeschke and C. D. Klaassen: Oxidative stress and the pathogenesis of cholestasis, Semin Liver Dis 30, 195-204 (2010))
24. G. Poli, Pathogenesis of liver fibrosis: role of oxidative stress, Mol Aspects Med 21, 49-98 (2000)) (Pubitemid 30642764)
25. S. Krahenbuhl and E. P. Brass: Fuel homeostasis and carnitine metabolism in rats with secondary biliary cirrhosis, Hepatology 14, 927-934 (1991))
26. O. E. Owen, F. A. Reichle, M. A. Mozzoli, T. Kreulen, M. S. Patel, I. B. Elfenbein, M. Golsorkhi, K. H. Chang, N. S. Rao, H. S. Sue and G. Boden: Hepatic, gut, and renal substrate flux rates in patients with hepatic cirrhosis, J Clin Invest 68, 240-252 (1981)) (Pubitemid 11048096)
27. H. Malhi, G. J. Gores and J. J. Lemasters: Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology 43, S31-44 (2006))
28. A. F. Attili, M. Angelico, A. Cantafora, D. Alvaro and L. Capocaccia: Bile acid-induced liver toxicity: relation to the hydrophobic-hydrophilic balance of bile acids, Med Hypotheses 19, 57-69 (1986)) (Pubitemid 16147457)
29. J. R. Spivey, S. F. Bronk and G. J. Gores: Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium, J Clin Invest 92, 17-24 (1993)) (Pubitemid 23208976)
30. A. P. Rolo, P. J. Oliveira, A. J. Moreno and C. M. Palmeira: Bile acids affect liver mitochondrial bioenergetics: possible relevance for cholestasis therapy, Toxicol Sci 57, 177-185 (2000))
31. K. Koyama, K. Ito, K. Ouchi and T. Sato: Mitochondrial function of rat liver in biliary obstruction, Tohoku J Exp Med 131, 59-69 (1980)) (Pubitemid 10013841)
32. I. A. Fraser, P. Shaffer, S. V. Tuttle, M. A. Lessler, E. C. Ellison and L. C. Carey: Hepatic recovery after biliary decompression of experimental obstructive jaundice, Am J Surg 158, 423-427 (1989)) (Pubitemid 19283806)
33. R. N. Younes, R. S. Poggetti, B. Fontes, M. M. Itinoshe, V. M. Yoshida, M. E. Carvalho and D. Birolini: Obstructive jaundice induces early depression of mitochondrial respiration in rat hepatocytes, Acta Cir Bras 22, 251-254 (2007))
34. L. Enochsson, B. Isaksson, L. Strommer, C. Erlanson-Albertsson and J. Permert: Bile duct obstruction is associated with early postoperative upregulation of liver uncoupling protein-2 and reduced circulating glucose concentration in the rat, Nutrition 26, 405-410 (2010))
35. K. Ozawa, O. Kitamura, Y. Yamaoka, T. Mizukami and T. Kamano: Role of portal blood on the enhancement of liver mitochondrial metabolism, Am J Surg 124, 16-20 (1972))
36. S. Krahenbuhl, S. Krahenbuhl-Glauser, J. Stucki, P. Gehr and J. Reichen: Stereological and functional analysis of liver mitochondria from rats with secondary biliary cirrhosis: impaired mitochondrial metabolism and increased mitochondrial content per hepatocyte, Hepatology 15, 1167-1172 (1992))
37. Y. Asanuma and K. Koyama: Effect of nonbiological hepatic assist on the mitochondrial function of the liver: basic consideration, Artif Organs 18, 367-370 (1994)) (Pubitemid 24167249)
38. M. Kanai, M. Tanaka, Y. Nimura, M. Nagino, T. Katoh and T. Ozawa: Mechanism of adaptive increase of respiratory enzymes in rat liver mitochondria during obstructive jaundice, Biochem Int 23, 1165-1173 (1991))
39. S. Krahenbuhl, J. Stucki and J. Reichen: Reduced activity of the electron transport chain in liver mitochondria isolated from rats with secondary biliary cirrhosis, Hepatology 15, 1160-1166 (1992))
40. M. Kanai, M. Tanaka, Y. Nimura, M. Nagino, T. Katoh and T. Ozawa: Mitochondrial dysfunction in the nonobstructed lobe of rat liver after selective biliary obstruction, Hepatogastroenterology 39, 385-391 (1992))
41. R. Kemp, O. Castro-e-Silva, J. S. Santos, A. K. Sankarankutty, R. B. Correa, C. F. Baldo, M. E. Souza and M. C. Jordani: Evaluation of the mitochondrial respiration of cardiac myocytes in rats submitted to mechanical bile duct obstruction, Acta Cir Bras 23 Suppl 1, 66-71; discussion 71 (2008)) (Pubitemid 351769180)
42. M. B. Hock and A. Kralli: Transcriptional control of mitochondrial biogenesis and function, Annu Rev Physiol 71, 177-203 (2009))
43. D. J. Pagliarini, S. E. Calvo, B. Chang, S. A. Sheth, S. B. Vafai, S. E. Ong, G. A. Walford, C. Sugiana, A. Boneh, W. K. Chen, D. E. Hill, M. Vidal, J. G. Evans, D. R. Thorburn, S. A. Carr and V. K. Mootha: A mitochondrial protein compendium elucidates complex I disease biology, Cell 134, 112-123 (2008)) (Pubitemid 351916708)
44. R. C. Scarpulla, Nuclear activators and coactivators in mammalian mitochondrial biogenesis, Biochim Biophys Acta 1576, 1-14 (2002)) (Pubitemid 34597079)
45. M. Falkenberg, M. Gaspari, A. Rantanen, A. Trifunovic, N. G. Larsson and C. M. Gustafsson: Mitochondrial transcription factors B1 and B2 activate transcription of human mtDNA, Nat Genet 31, 289-294 (2002))
46. D. Litonin, M. Sologub, Y. Shi, M. Savkina, M. Anikin, M. Falkenberg, C. M. Gustafsson and D. Temiakov: Human mitochondrial transcription revisited: only TFAM and TFB2M are required for transcription of the mitochondrial genes in vitro, J Biol Chem 285, 18129-18133 (2010))
47. M. Forestier, M. Solioz, F. Isbeki, C. Talos, J. Reichen and S. Krahenbuhl: Hepatic mitochondrial proliferation in rats with secondary biliary cirrhosis: time course and mechanisms, Hepatology 26, 386-391 (1997)) (Pubitemid 27328316)
48. M. J. Baker, A. E. Frazier, J. M. Gulbis and M. T. Ryan: Mitochondrial protein-import machinery: correlating structure with function, Trends Cell Biol 17, 456-464 (2007)) (Pubitemid 47499044)
49. J. Martin, K. Mahlke and N. Pfanner: Role of an energized inner membrane in mitochondrial protein import. Delta psi drives the movement of presequences, J Biol Chem 266, 18051-18057 (1991)) (Pubitemid 21908046)
50. O. Schmidt, N. Pfanner and C. Meisinger: Mitochondrial protein import: from proteomics to functional mechanisms, Nat Rev Mol Cell Biol 11, 655-667 (2010))
51. T. Lithgow, B. S. Glick and G. Schatz: The protein import receptor of mitochondria, Trends Biochem Sci 20, 98-101 (1995))
52. K. Yamano, Y. Yatsukawa, M. Esaki, A. E. Hobbs, R. E. Jensen and T. Endo: Tom20 and Tom22 share the common signal recognition pathway in mitochondrial protein import, J Biol Chem 283, 3799-3807 (2008))
53. H. Yamamoto, K. Fukui, H. Takahashi, S. Kitamura, T. Shiota, K. Terao, M. Uchida, M. Esaki, S. Nishikawa, T. Yoshihisa, K. Yamano and T. Endo: Roles of Tom70 in import of presequence-containing mitochondrial proteins, J Biol Chem 284, 31635-31646 (2009))
54. C. K. Fox, A. Furtwaengler, R. R. Nepomuceno, O. M. Martinez and S. M. Krams: Apoptotic pathways in primary biliary cirrhosis and autoimmune hepatitis, Liver 21, 272-279 (2001)) (Pubitemid 32677384)
55. A. Floreani, M. Guido, M. Bortolami, G. Della Zentil, C. Venturi, N. Pennelli and R. Naccarato: Relationship between apoptosis, tumour necrosis factor, and cell proliferation in chronic cholestasis, Dig Liver Dis 33, 570-575 (2001)) (Pubitemid 32994630)
56. P. Papakyriakou, M. Tzardi, V. Valatas, P. Kanavaros, E. Karydi, G. Notas, C. Xidakis and E. Kouroumalis: Apoptosis and apoptosis related proteins in chronic viral liver disease, Apoptosis 7, 133-141 (2002)) (Pubitemid 34273128)
57. Z. Jiang, Y. Liu, L. Savas, L. Smith, H. Bonkovsky, S. Baker and B. Banner: Frequency and distribution of DNA fragmentation as a marker of cell death in chronic liver diseases, Virchows Arch 431, 189-194 (1997)) (Pubitemid 27440363)
58. G. Kroemer, W. S. El-Deiry, P. Golstein, M. E. Peter, D. Vaux, P. Vandenabeele, B. Zhivotovsky, M. V. Blagosklonny, W. Malorni, R. A. Knight, M. Piacentini, S. Nagata, G. Melino and Nomenclature Committee on Cell Death: Classification of cell death: recommendations of the Nomenclature Committee on Cell Death, Cell Death Differ 12 Suppl 2, 1463-1467 (2005)) (Pubitemid 41553979)
59. H. Walczak and T. L. Haas: Biochemical analysis of the native TRAIL death-inducing signaling complex, Methods Mol Biol 414, 221-239 (2008))
60. X. M. Yin, K. Wang, A. Gross, Y. Zhao, S. Zinkel, B. Klocke, K. A. Roth and S. J. Korsmeyer: Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis, Nature 400, 886-891 (1999)) (Pubitemid 29406726)
61. Y. Zhao, S. Li, E. E. Childs, D. K. Kuharsky and X. M. Yin: Activation of pro-death Bcl-2 family proteins and mitochondria apoptosis pathway in tumor necrosis factoralpha- induced liver injury, J Biol Chem 276, 27432-27440 (2001))
62. H. Jaeschke and M. L. Bajt: Regulation of apoptotic signaling pathways in hepatocytes in vivo, Hepatology 37, 942-945 (2003))
63. P. J. Jost, S. Grabow, D. Gray, M. D. McKenzie, U. Nachbur, D. C. Huang, P. Bouillet, H. E. Thomas, C. Borner, J. Silke, A. Strasser and T. Kaufmann: XIAP discriminates between type I and type II FAS-induced apoptosis, Nature 460, 1035-1039 (2009))
64. S. Schungel, L. E. Buitrago-Molina, P. Nalapareddy, M. Lebofsky, M. P. Manns, H. Jaeschke, A. Gross and A. Vogel: The strength of the Fas ligand signal determines whether hepatocytes act as type 1 or type 2 cells in murine livers, Hepatology 50, 1558-1566 (2009))
65. D. Walter, K. Schmich, S. Vogel, R. Pick, T. Kaufmann, F. C. Hochmuth, A. Haber, K. Neubert, S. McNelly, F. von Weizsacker, I. Merfort, U. Maurer, A. Strasser and C. Borner: Switch from type II to I Fas/CD95 death signaling on in vitro culturing of primary hepatocytes, Hepatology 48, 1942-1953 (2008))
66. M. H. Schoemaker, W. M. Gommans, L. Conde de la Rosa, M. Homan, P. Klok, C. Trautwein, H. van Goor, K. Poelstra, H. J. Haisma, P. L. Jansen and H. Moshage: Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factorkappa B activation, J Hepatol 39, 153-161 (2003)) (Pubitemid 36920549)
67. H. Miyoshi, C. Rust, M. E. Guicciardi and G. J. Gores: NF-kappaB is activated in cholestasis and functions to reduce liver injury, Am J Pathol 158, 967-975 (2001)) (Pubitemid 32221788)
68. H. Miyoshi, C. Rust, P. J. Roberts, L. J. Burgart and G. J. Gores: Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas, Gastroenterology 117, 669-677 (1999)) (Pubitemid 29409254)
69. S. H. Oh, K. J. Yun, J. X. Nan, D. H. Sohn and B. H. Lee: Changes in expression and immunolocalization of protein associated with toxic bile salts-induced apoptosis in rat hepatocytes, Arch Toxicol 77, 110-115 (2003))
70. A. P. Rolo, P. J. Oliveira, A. J. Moreno and C. M. Palmeira: Chenodeoxycholate is a potent inducer of the permeability transition pore in rat liver mitochondria, Biosci Rep 21, 73-80 (2001)) (Pubitemid 32703515)
71. R. Botla, J. R. Spivey, H. Aguilar, S. F. Bronk and G. J. Gores: Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection, J Pharmacol Exp Ther 272, 930-938 (1995))
72. C. M. Rodrigues, G. Fan, X. Ma, B. T. Kren and C. J. Steer: A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation, J Clin Invest 101, 2790-2799 (1998)) (Pubitemid 28294588)
73. C. M. Rodrigues, G. Fan, P. Y. Wong, B. T. Kren and C. J. Steer: Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production, Mol Med 4, 165-178 (1998)) (Pubitemid 28223968)
74. B. Yerushalmi, R. Dahl, M. W. Devereaux, E. Gumpricht and R. J. Sokol: Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition, Hepatology 33, 616-626 (2001)) (Pubitemid 32185224)
75. H. Higuchi, H. Miyoshi, S. F. Bronk, H. Zhang, N. Dean and G. J. Gores: Bid antisense attenuates bile acidinduced apoptosis and cholestatic liver injury, J Pharmacol Exp Ther 299, 866-873 (2001)) (Pubitemid 33104953)
76. A. P. Rolo, C. M. Palmeira, J. M. Holy and K. B. Wallace: Role of mitochondrial dysfunction in combined bile acid-induced cytotoxicity: the switch between apoptosis and necrosis, Toxicol Sci 79, 196-204 (2004)) (Pubitemid 38660263)
77. W. A. Faubion, M. E. Guicciardi, H. Miyoshi, S. F. Bronk, P. J. Roberts, P. A. Svingen, S. H. Kaufmann and G. J. Gores: Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas, J Clin Invest 103, 137-145 (1999)) (Pubitemid 29031172)
78. H. Greim, D. Trulzsch, P. Czygan, J. Rudick, F. Hutterer, F. Schaffner and H. Popper: Mechanism of cholestasis. 6. Bile acids in human livers with or without biliary obstruction, Gastroenterology 63, 846-850 (1972))
79. H. Greim, D. Trulzsch, J. Roboz, K. Dressler, P. Czygan, F. Hutterer, F. Schaffner and H. Popper: Mechanism of cholestasis. 5. Bile acids in normal rat livers and in those after bile duct ligation, Gastroenterology 63, 837-845 (1972))
80. A. Kahraman, F. J. Barreyro, S. F. Bronk, N. W. Werneburg, J. L. Mott, Y. Akazawa, H. C. Masuoka, C. L. Howe and G. J. Gores: TRAIL mediates liver injury by the innate immune system in the bile duct-ligated mouse, Hepatology 47, 1317-1330 (2008)) (Pubitemid 351547918)
81. T. Sodeman, S. F. Bronk, P. J. Roberts, H. Miyoshi and G. J. Gores: Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas, Am J Physiol Gastrointest Liver Physiol 278, G992-9 (2000)) (Pubitemid 30439179)
82. H. Higuchi, J. H. Yoon, A. Grambihler, N. Werneburg, S. F. Bronk and G. J. Gores: Bile acids stimulate cFLIP phosphorylation enhancing TRAIL-mediated apoptosis, J Biol Chem 278, 454-461 (2003)) (Pubitemid 36043596)
83. H. Higuchi, A. Grambihler, A. Canbay, S. F. Bronk and G. J. Gores: Bile acids up-regulate death receptor 5/TRAIL-receptor 2 expression via a c-Jun N-terminal kinase-dependent pathway involving Sp1, J Biol Chem 279, 51-60 (2004)) (Pubitemid 38044798)
84. H. Higuchi, S. F. Bronk, M. Taniai, A. Canbay and G. J. Gores: Cholestasis increases tumor necrosis factorrelated apoptotis-inducing ligand (TRAIL)-R2/DR5 expression and sensitizes the liver to TRAIL-mediated cytotoxicity, J Pharmacol Exp Ther 303, 461-467 (2002)) (Pubitemid 35231214)
85. J. S. Gujral, J. Liu, A. Farhood and H. Jaeschke: Reduced oncotic necrosis in Fas receptor-deficient C57BL/6J-lpr mice after bile duct ligation, Hepatology 40, 998-1007 (2004)) (Pubitemid 39288134)
86. J. J. Maher, What doesn't kill you makes you stronger: how hepatocytes survive prolonged cholestasis, Hepatology 39, 1141-1143 (2004)) (Pubitemid 38428953)
87. M. J. Lieser, J. Park, S. Natori, B. A. Jones, S. F. Bronk and G. J. Gores: Cholestasis confers resistance to the rat liver mitochondrial permeability transition, Gastroenterology 115, 693-701 (1998)) (Pubitemid 28397305)
88. A. Vogel, J. E. Aslan, H. Willenbring, C. Klein, M. Finegold, H. Mount, G. Thomas and M. Grompe: Sustained phosphorylation of Bid is a marker for resistance to Fasinduced apoptosis during chronic liver diseases, Gastroenterology 130, 104-119 (2006)) (Pubitemid 43049841)
89. C. M. Payne, C. L. Crowley-Weber, K. Dvorak, C. Bernstein, H. Bernstein, H. Holubec, C. Crowley and H. Garewal: Mitochondrial perturbation attenuates bile acidinduced cytotoxicity, Cell Biol Toxicol 21, 215-231 (2005)) (Pubitemid 41740015)
90. S. Faouzi, B. E. Burckhardt, J. C. Hanson, C. B. Campe, L. W. Schrum, R. A. Rippe and J. J. Maher: Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-kappa B-independent, caspase-3- dependent pathway, J Biol Chem 276, 49077-49082 (2001))
91. A. Canbay, P. Taimr, N. Torok, H. Higuchi, S. Friedman and G. J. Gores: Apoptotic body engulfment by a human stellate cell line is profibrogenic, Lab Invest 83, 655-663 (2003)) (Pubitemid 36618044)
92. A. Canbay, A. E. Feldstein, H. Higuchi, N. Werneburg, A. Grambihler, S. F. Bronk and G. J. Gores: Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression, Hepatology 38, 1188-1198 (2003)) (Pubitemid 37314827)
93. H. L. Reeves and S. L. Friedman: Activation of hepatic stellate cells - a key issue in liver fibrosis, Front Biosci 7, d808-26 (2002))
94. A. Canbay, S. Friedman and G. J. Gores: Apoptosis: the nexus of liver injury and fibrosis, Hepatology 39, 273-278 (2004)) (Pubitemid 38222163)
95. G. Vendemiale, I. Grattagliano, L. Lupo, V. Memeo and E. Altomare: Hepatic oxidative alterations in patients with extra-hepatic cholestasis. Effect of surgical drainage, J Hepatol 37, 601-605 (2002)) (Pubitemid 35305539)
96. A. Aboutwerat, P. W. Pemberton, A. Smith, P. C. Burrows, R. F. McMahon, S. K. Jain and T. W. Warnes: Oxidant stress is a significant feature of primary biliary cirrhosis, Biochim Biophys Acta 1637, 142-150 (2003)) (Pubitemid 36287408)
97. K. Kawata, Y. Kobayashi, K. Souda, K. Kawamura, S. Sumiyoshi, Y. Takahashi, H. Noritake, S. Watanabe, T. Suehiro and H. Nakamura: Enhanced hepatic Nrf2 activation after ursodeoxycholic acid treatment in patients with primary biliary cirrhosis, Antioxid Redox Signal 13, 259-268 (2010))
98. S. Sakaguchi and S. Furusawa: Oxidative stress and septic shock: metabolic aspects of oxygen-derived free radicals generated in the liver during endotoxemia, FEMS Immunol Med Microbiol 47, 167-177 (2006)) (Pubitemid 43881736)
99. P. Ljubuncic, Z. Tanne and A. Bomzon: Evidence of a systemic phenomenon for oxidative stress in cholestatic liver disease, Gut 47, 710-716 (2000))
100. H. Sies and E. Cadenas: Oxidative stress: damage to intact cells and organs, Philos Trans R Soc Lond B Biol Sci 311, 617-631 (1985))
101. N. Alptekin, G. Mehmetcik, M. Uysal and G. Aykactoker: Evidence for oxidative stress in the hepatic mitochondria of bile duct ligated rats, Pharmacol Res 36, 243-247 (1997)) (Pubitemid 27480724)
102. E. Purucker, R. Winograd, E. Roeb and S. Matern: Glutathione status in liver and plasma during development of biliary cirrhosis after bile duct ligation, Res Exp Med (Berl) 198, 167-174 (1998)) (Pubitemid 29008251)
103. Y. T. Huang, Y. C. Hsu, C. J. Chen, C. T. Liu and Y. H. Wei: Oxidative-stress-related changes in the livers of bile-duct-ligated rats, J Biomed Sci 10, 170-178 (2003))
104. H. Yang, K. Ko, M. Xia, T. W. Li, P. Oh, J. Li and S. C. Lu: Induction of avian musculoaponeurotic fibrosarcoma proteins by toxic bile acid inhibits expression of glutathione synthetic enzymes and contributes to cholestatic liver injury in mice, Hepatology 51, 1291-1301 (2010))
105. A. Colell, C. Garcia-Ruiz, M. Miranda, E. Ardite, M. Mari, A. Morales, F. Corrales, N. Kaplowitz and J. C. Fernandez-Checa: Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to tumor necrosis factor, Gastroenterology 115, 1541-1551 (1998)) (Pubitemid 28546006)
106. S. Krahenbuhl, C. Talos, B. H. Lauterburg and J. Reichen: Reduced antioxidative capacity in liver mitochondria from bile duct ligated rats, Hepatology 22, 607-612 (1995))
107. R. J. Sokol, M. Devereaux and R. A. Khandwala: Effect of dietary lipid and vitamin E on mitochondrial lipid peroxidation and hepatic injury in the bile duct-ligated rat, J Lipid Res 32, 1349-1357 (1991))
108. T. Nguyen, P. Nioi and C. B. Pickett: The Nrf2- antioxidant response element signaling pathway and its activation by oxidative stress, J Biol Chem 284, 13291-13295 (2009))
109. K. Okada, J. Shoda, K. Taguchi, J. M. Maher, K. Ishizaki, Y. Inoue, M. Ohtsuki, N. Goto, K. Takeda, H. Utsunomiya, K. Oda, E. Warabi, T. Ishii, K. Osaka, I. Hyodo and M. Yamamoto: Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice, Am J Physiol Gastrointest Liver Physiol 295, G735-47 (2008))
110. S. Arisawa, K. Ishida, N. Kameyama, J. Ueyama, A. Hattori, Y. Tatsumi, H. Hayashi, M. Yano, K. Hayashi, Y. Katano, H. Goto, K. Takagi and S. Wakusawa: Ursodeoxycholic acid induces glutathione synthesis through activation of PI3K/Akt pathway in HepG2 cells, Biochem Pharmacol 77, 858-866 (2009))
111. R. J. Sokol, J. M. McKim Jr, M. C. Goff, S. Z. Ruyle, M. W. Devereaux, D. Han, L. Packer and G. Everson: Vitamin E reduces oxidant injury to mitochondria and the hepatotoxicity of taurochenodeoxycholic acid in the rat, Gastroenterology 114, 164-174 (1998)) (Pubitemid 28020966)
112. R. J. Sokol, M. S. Straka, R. Dahl, M. W. Devereaux, B. Yerushalmi, E. Gumpricht, N. Elkins and G. Everson: Role of oxidant stress in the permeability transition induced in rat hepatic mitochondria by hydrophobic bile acids, Pediatr Res 49, 519-531 (2001)) (Pubitemid 32274966)
113. Z. Zhong, M. Froh, M. D. Wheeler, O. Smutney, T. G. Lehmann and R. G. Thurman: Viral gene delivery of superoxide dismutase attenuates experimental cholestasisinduced liver fibrosis in the rat, Gene Ther 9, 183-191 (2002)) (Pubitemid 34189578)
114. R. J. Sokol, M. W. Devereaux and R. Khandwala: Effect of oxypurinol, a xanthine oxidase inhibitor, on hepatic injury in the bile duct-ligated rat, Pediatr Res 44, 397-401 (1998)) (Pubitemid 28389998)
115. M. R. Ebrahimkhani, H. Sadeghipour, M. Dehghani, S. Kiani, S. Payabvash, K. Riazi, H. Honar, P. Pasalar, N. Mirazi, M. Amanlou, H. Farsam and A. R. Dehpour: Homocysteine alterations in experimental cholestasis and its subsequent cirrhosis, Life Sci 76, 2497-2512 (2005)) (Pubitemid 40341965)
116. V. Baron and P. Muriel: Role of glutathione, lipid peroxidation and antioxidants on acute bile-duct obstruction in the rat, Biochim Biophys Acta 1472, 173-180 (1999)) (Pubitemid 29486527)
117. Y. Fang, S. I. Han, C. Mitchell, S. Gupta, E. Studer, S. Grant, P. B. Hylemon and P. Dent: Bile acids induce mitochondrial ROS, which promote activation of receptor tyrosine kinases and signaling pathways in rat hepatocytes, Hepatology 40, 961-971 (2004)) (Pubitemid 39288130)
118. L. Qiao, A. Yacoub, E. Studer, S. Gupta, X. Y. Pei, S. Grant, P. B. Hylemon and P. Dent: Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes, Hepatology 35, 779-789 (2002)) (Pubitemid 34258371)
119. L. Qiao, E. Studer, K. Leach, R. McKinstry, S. Gupta, R. Decker, R. Kukreja, K. Valerie, P. Nagarkatti, W. El Deiry, J. Molkentin, R. Schmidt-Ullrich, P. B. Fisher, S. Grant, P. B. Hylemon and P. Dent: Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis, Mol Biol Cell 12, 2629-2645 (2001)) (Pubitemid 33051930)
120. E. Chavez, R. Moreno-Sanchez, M. E. Torres-Marquez, C. Zazueta, C. Bravo, S. Rodriquez-Enriquez, C. Garcia, J. S. Rodriguez and F. Martinez: Modulation of matrix Ca2+ content by the ADP/ATP carrier in brown adipose tissue mitochondria. Influence of membrane lipid composition, J Bioenerg Biomembr 28, 69-76 (1996))
121. E. Novo and M. Parola: Redox mechanisms in hepatic chronic wound healing and fibrogenesis, Fibrogenesis Tissue Repair 1, 5 (2008))
122. H. B. Suliman, M. S. Carraway, K. E. Welty-Wolf, A. R. Whorton and C. A. Piantadosi: Lipopolysaccharide stimulates mitochondrial biogenesis via activation of nuclear respiratory factor-1, J Biol Chem 278, 41510-41518 (2003)) (Pubitemid 37280980)
123. H. B. Suliman, M. S. Carraway and C. A. Piantadosi: Postlipopolysaccharide oxidative damage of mitochondrial DNA, Am J Respir Crit Care Med 167, 570-579 (2003))
124. M. G. Roma and E. J. Sanchez Pozzi: Oxidative stress: a radical way to stop making bile, Ann Hepatol 7, 16-33 (2008)) (Pubitemid 351468534)
125. S. Sekine, K. Ito and T. Horie: Canalicular Mrp2 localization is reversibly regulated by the intracellular redox status, Am J Physiol Gastrointest Liver Physiol 295, G1035-41 (2008))
126. J. S. Gujral, A. Farhood, M. L. Bajt and H. Jaeschke: Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct-ligated mice, Hepatology 38, 355-363 (2003)) (Pubitemid 36919856)
127. A. Bohan, W. S. Chen, L. A. Denson, M. A. Held and J. L. Boyer: Tumor necrosis factor alpha-dependent upregulation of Lrh-1 and Mrp3(Abcc3) reduces liver injury in obstructive cholestasis, J Biol Chem 278, 36688-36698 (2003)) (Pubitemid 37140001)
128. S. Gehring, E. M. Dickson, M. E. San Martin, N. van Rooijen, E. F. Papa, M. W. Harty, T. F. Tracy Jr and S. H. Gregory: Kupffer cells abrogate cholestatic liver injury in mice, Gastroenterology 130, 810-822 (2006)) (Pubitemid 43374530)
129. S. L. Friedman, Mechanisms of hepatic fibrogenesis, Gastroenterology 134, 1655-1669 (2008)) (Pubitemid 351615417)
130. H. Jaeschke, G. J. Gores, A. I. Cederbaum, J. A. Hinson, D. Pessayre and J. J. Lemasters: Mechanisms of hepatotoxicity, Toxicol Sci 65, 166-176 (2002)) (Pubitemid 34121108)
131. J. A. Kennedy, W. D. Clements, S. J. Kirk, M. D. McCaigue, G. R. Campbell, P. J. Erwin, M. I. Halliday and B. J. Rowlands: Characterization of the Kupffer cell response to exogenous endotoxin in a rodent model of obstructive jaundice, Br J Surg 86, 628-633 (1999)) (Pubitemid 29248355)
132. M. Trauner, P. Fickert and R. E. Stauber: Inflammation-induced cholestasis, J Gastroenterol Hepatol 14, 946-959 (1999)) (Pubitemid 29487289)
133. J. F. Whiting, R. M. Green, A. B. Rosenbluth and J. L. Gollan: Tumor necrosis factor-alpha decreases hepatocyte bile salt uptake and mediates endotoxin-induced cholestasis, Hepatology 22, 1273-1278 (1995))
134. R. H. Moseley, W. Wang, H. Takeda, K. Lown, L. Shick, M. Ananthanarayanan and F. J. Suchy: Effect of endotoxin on bile acid transport in rat liver: a potential model for sepsis-associated cholestasis, Am J Physiol 271, G137-46 (1996)) (Pubitemid 26299736)
135. D. Han, M. D. Ybanez, S. Ahmadi, K. Yeh and N. Kaplowitz: Redox regulation of tumor necrosis factor signaling, Antioxid Redox Signal 11, 2245-2263 (2009))
136. W. S. Lee and R. J. Sokol: Mitochondrial hepatopathies: advances in genetics and pathogenesis, Hepatology 45, 1555-1565 (2007)) (Pubitemid 46918340)
137. W. R. Treem and R. J. Sokol: Disorders of the mitochondria, Semin Liver Dis 18, 237-253 (1998)) (Pubitemid 28425861)
138. R. J. Sokol and W. R. Treem: Mitochondria and childhood liver diseases, J Pediatr Gastroenterol Nutr 28, 4-16 (1999)) (Pubitemid 29292868)
139. D. R. Johns, Seminars in medicine of the Beth Israel Hospital, Boston. Mitochondrial DNA and disease, N Engl J Med 333, 638-644 (1995))
140. I. Goncalves, D. Hermans, D. Chretien, P. Rustin, A. Munnich, J. M. Saudubray, F. Van Hoof, R. Reding, J. de Ville de Goyet and J. B. Otte: Mitochondrial respiratory chain defect: a new etiology for neonatal cholestasis and early liver insufficiency, J Hepatol 23, 290-294 (1995))
141. M. Komura, K. Chijiiwa, T. Naito, N. Kameoka, H. Yamashita, K. Yamaguchi, S. Kuroki and M. Tanaka: Sequential changes of energy charge, lipoperoxide level, and DNA synthesis rate of the liver following biliary obstruction in rats, J Surg Res 61, 503-508 (1996)) (Pubitemid 26087704)
142. L. Krahenbuhl, M. Schafer and S. Krahenbuhl: Reversibility of hepatic mitochondrial damage in rats with long-term cholestasis, J Hepatol 28, 1000-1007 (1998)) (Pubitemid 28275979)
143. P. H. Ducluzeau, A. Lachaux, R. Bouvier, N. Streichenberger, G. Stepien and B. Mousson: Depletion of mitochondrial DNA associated with infantile cholestasis and progressive liver fibrosis, J Hepatol 30, 149-155 (1999)) (Pubitemid 29023664)
144. R. C. Scarpulla, Transcriptional paradigms in mammalian mitochondrial biogenesis and function, Physiol Rev 88, 611-638 (2008)) (Pubitemid 351520089)
145. L. R. Hagey, D. L. Crombie, E. Espinosa, M. C. Carey, H. Igimi and A. F. Hofmann: Ursodeoxycholic acid in the Ursidae: biliary bile acids of bears, pandas, and related carnivores, J Lipid Res 34, 1911-1917 (1993)) (Pubitemid 23324966)
146. T. Ikegami and Y. Matsuzaki: Ursodeoxycholic acid: Mechanism of action and novel clinical applications, Hepatol Res 38, 123-131 (2008))
147. C. M. Rodrigues, X. Ma, C. Linehan-Stieers, G. Fan, B. T. Kren and C. J. Steer: Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation, Cell Death Differ 6, 842-854 (1999)) (Pubitemid 29488082)
148. M. H. Schoemaker, L. Conde de la Rosa, M. Buist-Homan, T. E. Vrenken, R. Havinga, K. Poelstra, H. J. Haisma, P. L. Jansen and H. Moshage: Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways, Hepatology 39, 1563-1573 (2004)) (Pubitemid 38702657)
149. Y. Calmus and R. Poupon: Ursodeoxycholic acid (UDCA) in the treatment of chronic cholestatic diseases, Biochimie 73, 1335-1338 (1991))
150. Y. Calmus, P. Gane, P. Rouger and R. Poupon: Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid, Hepatology 11, 12-15 (1990)) (Pubitemid 20075095)
151. C. M. Van Nieuwkerk, R. P. Elferink, A. K. Groen, R. Ottenhoff, G. N. Tytgat, K. P. Dingemans, M. A. Van Den Bergh Weerman and G. J. Offerhaus: Effects of Ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene, Gastroenterology 111, 165-171 (1996)) (Pubitemid 26226896)
152. U. Beuers, M. Bilzer, A. Chittattu, G. A. Kullak-Ublick, D. Keppler, G. Paumgartner and F. Dombrowski: Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase Cdependent mechanisms in cholestatic rat liver, Hepatology 33, 1206-1216 (2001)) (Pubitemid 32378221)
153. R. P. Jazrawi, J. S. de Caestecker, P. M. Goggin, A. J. Britten, A. E. Joseph, J. D. Maxwell and T. C. Northfield: Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid, Gastroenterology 106, 134-142 (1994)) (Pubitemid 24011874)
154. R. Wimmer, S. Hohenester, T. Pusl, G. U. Denk, C. Rust and U. Beuers: Tauroursodeoxycholic acid exerts anticholestatic effects by a cooperative cPKC alpha-/PKAdependent mechanism in rat liver, Gut 57, 1448-1454 (2008))
155. C. R. Webster and M. S. Anwer: Cyclic adenosine monophosphate-mediated protection against bile acidinduced apoptosis in cultured rat hepatocytes, Hepatology 27, 1324-1331 (1998)) (Pubitemid 28227860)
156. M. Marzioni, H. Francis, A. Benedetti, Y. Ueno, G. Fava, J. Venter, R. Reichenbach, M. G. Mancino, R. Summers, G. Alpini and S. Glaser: Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts, Am J Pathol 168, 398-409 (2006)) (Pubitemid 43271139)
157. H. Mitsuyoshi, T. Nakashima, Y. Sumida, T. Yoh, Y. Nakajima, H. Ishikawa, K. Inaba, Y. Sakamoto, T. Okanoue and K. Kashima: Ursodeoxycholic acid protects hepatocytes against oxidative injury via induction of antioxidants, Biochem Biophys Res Commun 263, 537-542 (1999)) (Pubitemid 29467230)
158. R. A. Smith, C. M. Porteous, C. V. Coulter and M. P. Murphy: Selective targeting of an antioxidant to mitochondria, Eur J Biochem 263, 709-716 (1999)) (Pubitemid 29361943)
159. M. P. Murphy and R. A. Smith: Targeting antioxidants to mitochondria by conjugation to lipophilic cations, Annu Rev Pharmacol Toxicol 47, 629-656 (2007))
160. K. Zhao, G. M. Zhao, D. Wu, Y. Soong, A. V. Birk, P. W. Schiller and H. H. Szeto: Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury, J Biol Chem 279, 34682-34690 (2004)) (Pubitemid 39318098)
161. M. F. Ross, G. F. Kelso, F. H. Blaikie, A. M. James, H. M. Cocheme, A. Filipovska, T. Da Ros, T. R. Hurd, R. A. Smith and M. P. Murphy: Lipophilic triphenylphosphonium cations as tools in mitochondrial bioenergetics and free radical biology, Biochemistry (Mosc) 70, 222-230 (2005)) (Pubitemid 40512331)
162. G. F. Kelso, C. M. Porteous, C. V. Coulter, G. Hughes, W. K. Porteous, E. C. Ledgerwood, R. A. Smith and M. P. Murphy: Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties, J Biol Chem 276, 4588-4596 (2001))
163. J. Asin-Cayuela, A. R. Manas, A. M. James, R. A. Smith and M. P. Murphy: Fine-tuning the hydrophobicity of a mitochondria-targeted antioxidant, FEBS Lett 571, 9-16 (2004)) (Pubitemid 38992915)
164. A. M. James, H. M. Cocheme, R. A. Smith and M. P. Murphy: Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools, J Biol Chem 280, 21295-21312 (2005)) (Pubitemid 40805692)
165. R. A. Smith, C. M. Porteous, A. M. Gane and M. P. Murphy: Delivery of bioactive molecules to mitochondria in vivo, Proc Natl Acad Sci U S A 100, 5407-5412 (2003)) (Pubitemid 36542718)
166. S. Rodriguez-Cuenca, H. M. Cocheme, A. Logan, I. Abakumova, T. A. Prime, C. Rose, A. Vidal-Puig, A. C. Smith, D. C. Rubinsztein, I. M. Fearnley, B. A. Jones, S. Pope, S. J. Heales, B. Y. Lam, S. G. Neogi, I. McFarlane, A. M. James, R. A. Smith and M. P. Murphy: Consequences of long-term oral administration of the mitochondria-targeted antioxidant MitoQ to wild-type mice, Free Radic Biol Med 48, 161-172 (2010))
167. B. J. Snow, F. L. Rolfe, M. M. Lockhart, C. M. Frampton, J. D. O'Sullivan, V. Fung, R. A. Smith, M. P. Murphy, K. M. Taylor and Protect Study Group: A doubleblind, placebo-controlled study to assess the mitochondriatargeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease, Mov Disord 25, 1670-1674 (2010))
168. V. J. Adlam, J. C. Harrison, C. M. Porteous, A. M. James, R. A. Smith, M. P. Murphy and I. A. Sammut: Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury, FASEB J 19, 1088-1095 (2005)) (Pubitemid 40946434)
169. J. Neuzil, B. S. Rayner, H. C. Lowe and P. K. Witting: Oxidative stress in myocardial ischaemia reperfusion injury: a renewed focus on a long-standing area of heart research, Redox Rep 10, 187-197 (2005)) (Pubitemid 44111135)
170. D. Graham, N. N. Huynh, C. A. Hamilton, E. Beattie, R. A. Smith, H. M. Cocheme, M. P. Murphy and A. F. Dominiczak: Mitochondria-targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy, Hypertension 54, 322-328 (2009))
171. D. A. Lowes, B. M. Thottakam, N. R. Webster, M. P. Murphy and H. F. Galley: The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsis, Free Radic Biol Med 45, 1559-1565 (2008))
172. E. J. Gane, F. Weilert, D. W. Orr, G. F. Keogh, M. Gibson, M. M. Lockhart, C. M. Frampton, K. M. Taylor, R. A. Smith and M. P. Murphy: The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients, Liver Int 30, 1019-1026 (2010))